Effects of Inflammatory Cell Death Caused by Catheter Ablation on Atrial Fibrillation

References

• Santhanakrishnan R, Wang N, Larson MG, et al. Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation. 2016;133(5):484–492. doi:10.1161/CIRCULATIONAHA.115.018614
   PubMed Web of Science ®Google Scholar
• Şaylık F, Çınar T, Akbulut T, Hayıroğlu M. Comparison of catheter ablation and medical therapy for atrial fibrillation in heart failure patients: a meta-analysis of randomized controlled trials. Heart Lung. 2023;57:69–74.
   PubMed Web of Science ®Google Scholar
• Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659–666. doi:10.1056/NEJM199809033391003
   PubMed Web of Science ®Google Scholar
• Nogami A, Kurita T, Abe H, et al. JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias. Circ J. 2021;85(7):1104–1244. doi:10.1253/circj.CJ-20-0637
   PubMed Web of Science ®Google Scholar
• Li P, Dong XR, Zhang B, et al. Molecular mechanism and therapeutic targeting of necrosis, apoptosis, pyroptosis, and autophagy in cardiovascular disease. Chin Med J. 2021;134(22):2647–2655. doi:10.1097/cm9.0000000000001772
   PubMed Web of Science ®Google Scholar
• Ji N, Qi Z, Wang Y, et al. Pyroptosis: a new regulating mechanism in cardiovascular disease. J Inflamm Res. 2021;14:2647–2666. doi:10.2147/jir.S308177
   PubMed Web of Science ®Google Scholar
• Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26(4):239–257. doi:10.1038/bjc.1972.33
   PubMed Web of Science ®Google Scholar
• Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 1994;94(4):1621–1628. doi:10.1172/jci117504
   PubMed Web of Science ®Google Scholar
• James TN. Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias. Circulation. 1994;90(1):556–573.
   PubMed Web of Science ®Google Scholar
• James TN, Terasaki F, Pavlovich ER, Vikhert AM. Apoptosis and pleomorphic micromitochondriosis in the sinus nodes surgically excised from five patients with the long QT syndrome. J Lab Clin Med. 1993;122(3):309–323.
   PubMed Web of Science ®Google Scholar
• Kuramochi Y, Guo X, Sawyer DB, Lim CC. Rapid electrical stimulation induces early activation of kinase signal transduction pathways and apoptosis in adult rat ventricular myocytes. Exp Physiol. 2006;91(4):773–780. doi:10.1113/expphysiol.2006.033894
   PubMed Web of Science ®Google Scholar
• Aimé-Sempé C, Folliguet T, Rücker-Martin C, et al. Myocardial cell death in fibrillating and dilated human right atria. J Am Coll Cardiol. 1999;34(5):1577–1586. doi:10.1016/s0735-1097(99)00382-4
   PubMed Web of Science ®Google Scholar
• Zhao J, Li J, Li W, et al. Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing. Br J Pharmacol. 2010;159(8):1584–1594. doi:10.1111/j.1476-5381.2009.00551.x
   PubMed Web of Science ®Google Scholar
• Trappe K, Thomas D, Bikou O, et al. Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot study. Eur Heart J. 2013;34(2):147–157. doi:10.1093/eurheartj/ehr269
   PubMed Web of Science ®Google Scholar
• Fedai H, Altiparmak IH, Tascanov MB, et al. The relationship between oxidative stress and autophagy and apoptosis in patients with paroxysmal atrial fibrillation. Scand J Clin Lab Invest. 2022;82(5):391–397. doi:10.1080/00365513.2022.2100274
   PubMed Web of Science ®Google Scholar
• Osmancik P, Peroutka Z, Budera P, et al. Decreased apoptosis following successful ablation of atrial fibrillation. Cardiology. 2010;116(4):302–307. doi:10.1159/000319619
   PubMed Web of Science ®Google Scholar
• Adamo L, Rocha-Resende C, Prabhu SD, Mann DL. Reappraising the role of inflammation in heart failure. Nat Rev Cardiol. 2020;17(5):269–285. doi:10.1038/s41569-019-0315-x
   PubMed Web of Science ®Google Scholar
• Mann DL, Topkara VK, Evans S, Barger PM. Innate immunity in the adult mammalian heart: for whom the cell tolls. Trans Am Clin Climatol Assoc. 2010;121:34–50.
   PubMedGoogle Scholar
• Mouton AJ, DeLeon-Pennell KY, Rivera Gonzalez OJ, et al. Mapping macrophage polarization over the myocardial infarction time continuum. Basic Res Cardiol. 2018;113(4):26. doi:10.1007/s00395-018-0686-x
   PubMed Web of Science ®Google Scholar
• Daseke MJ, Valerio FM, Kalusche WJ, Ma Y, DeLeon-Pennell KY, Lindsey ML. Neutrophil proteome shifts over the myocardial infarction time continuum. Basic Res Cardiol. 2019;114(5):37. doi:10.1007/s00395-019-0746-x
   PubMed Web of Science ®Google Scholar
• Rurik JG, Aghajanian H, Epstein JA. Immune Cells and immunotherapy for cardiac injury and repair. Circ Res. 2021;128(11):1766–1779. doi:10.1161/circresaha.121.318005
   PubMed Web of Science ®Google Scholar
• Majidi M, Kosinski AS, Al-Khatib SM, et al. Reperfusion ventricular arrhythmia ‘bursts’ in TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction: a more precise definition of reperfusion arrhythmias. Europace. 2008;10(8):988–997. doi:10.1093/europace/eun123
   PubMed Web of Science ®Google Scholar
• Majidi M, Kosinski AS, Al-Khatib SM, et al. Reperfusion ventricular arrhythmia ‘bursts’ predict larger infarct size despite TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction. Eur Heart J. 2009;30(7):757–764. doi:10.1093/eurheartj/ehp005
   PubMed Web of Science ®Google Scholar
• van der Weg K, Majidi M, Haeck JD, et al. Ventricular arrhythmia burst is an independent indicator of larger infarct size even in optimal reperfusion in STEMI. J Electrocardiol. 2016;49(3):345–352. doi:10.1016/j.jelectrocard.2016.03.013
   PubMed Web of Science ®Google Scholar
• Belkouche A, Yao H, Putot A, et al. The multifaceted interplay between atrial fibrillation and myocardial infarction: a review. J Clin Med. 2021;10(2). doi:10.3390/jcm10020198
   PubMed Web of Science ®Google Scholar
• Bocharov AV, Popov LV, Lagkuev MD. The frequency of atrial infarction in patients with supraventricular arrhythmias. Kardiologiia. 2022;62(3):28–31. doi:10.18087/cardio.2022.3.n1648
   PubMed Web of Science ®Google Scholar
• Álvarez-García J, Vives-Borrás M, Gomis P, et al. Electrophysiological effects of selective atrial coronary artery occlusion in humans. Circulation. 2016;133(23):2235–2242. doi:10.1161/circulationaha.116.021700
   PubMed Web of Science ®Google Scholar
• Biccirè FG, Pastori D, Torromeo C, et al. Acute atrial ischemia associates with early but not late new-onset atrial fibrillation in STEMI patients treated with primary PCI: relationship with in-hospital outcomes. J Cardiol. 2021;78(5):368–374. doi:10.1016/j.jjcc.2021.05.013
   PubMed Web of Science ®Google Scholar
• Shiba T, Kondo Y, Senoo K, et al. Proximal occlusion in the right coronary artery involving the atrial branch as a strong predictor of new-onset atrial fibrillation in acute myocardial infarction. Int Heart J. 2019;60(6):1308–1314. doi:10.1536/ihj.18-713
   PubMed Web of Science ®Google Scholar
• Alasady M, Shipp NJ, Brooks AG, et al. Myocardial infarction and atrial fibrillation: importance of atrial ischemia. Circ Arrhythm Electrophysiol. 2013;6(4):738–745. doi:10.1161/circep.113.000163
   PubMed Web of Science ®Google Scholar
• Nishida K, Qi XY, Wakili R, et al. Mechanisms of atrial tachyarrhythmias associated with coronary artery occlusion in a chronic canine model. Circulation. 2011;123(2):137–146. doi:10.1161/circulationaha.110.972778
   PubMed Web of Science ®Google Scholar
• Avula UMR, Hernandez JJ, Yamazaki M, et al. Atrial infarction-induced spontaneous focal discharges and atrial fibrillation in sheep: role of dantrolene-sensitive aberrant ryanodine receptor calcium release. Circ Arrhythm Electrophysiol. 2018;11(3):e005659. doi:10.1161/circep.117.005659
   PubMed Web of Science ®Google Scholar
• Liu M, Li W, Wang H, et al. CTRP9 ameliorates atrial inflammation, fibrosis, and vulnerability to atrial fibrillation in post-myocardial infarction rats. J Am Heart Assoc. 2019;8(21):e013133. doi:10.1161/jaha.119.013133
   PubMed Web of Science ®Google Scholar
• Beiert T, Tiyerili V, Knappe V, et al. Relaxin reduces susceptibility to post-infarct atrial fibrillation in mice due to anti-fibrotic and anti-inflammatory properties. Biochem Biophys Res Commun. 2017;490(3):643–649. doi:10.1016/j.bbrc.2017.06.091
   PubMed Web of Science ®Google Scholar
• Zhou W, Yuan J. Necroptosis in health and diseases. Semin Cell Dev Biol. 2014;35:14–23. doi:10.1016/j.semcdb.2014.07.013
   PubMed Web of Science ®Google Scholar
• Koudstaal S, Oerlemans MI, Van der Spoel TI, et al. Necrostatin-1 alleviates reperfusion injury following acute myocardial infarction in pigs. Eur J Clin Invest. 2015;45(2):150–159. doi:10.1111/eci.12391
   PubMed Web of Science ®Google Scholar
• Guo X, Yin H, Li L, et al. Cardioprotective role of tumor necrosis factor receptor-associated factor 2 by suppressing apoptosis and necroptosis. Circulation. 2017;136(8):729–742. doi:10.1161/circulationaha.116.026240
   PubMed Web of Science ®Google Scholar
• Szobi A, Gonçalvesová E, Varga ZV, et al. Analysis of necroptotic proteins in failing human hearts. J Transl Med. 2017;15(1):86. doi:10.1186/s12967-017-1189-5
   PubMedGoogle Scholar
• Fu Y, Jiang T, Sun H, et al. Necroptosis is required for atrial fibrillation and involved in aerobic exercise-conferred cardioprotection. J Cell Mol Med. 2021;25(17):8363–8375. doi:10.1111/jcmm.16796
   PubMed Web of Science ®Google Scholar
• Li L, Chen Y, Doan J, Murray J, Molkentin JD, Liu Q. Transforming growth factor β-activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling. Circulation. 2014;130(24):2162–2172. doi:10.1161/circulationaha.114.011195
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072. doi:10.1016/j.cell.2012.03.042
   PubMed Web of Science ®Google Scholar
• Friedmann Angeli JP, Schneider M, Proneth B, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16(12):1180–1191. doi:10.1038/ncb3064
   PubMed Web of Science ®Google Scholar
• Proneth B, Conrad M. Ferroptosis and necroinflammation, a yet poorly explored link. Cell Death Differ. 2019;26(1):14–24. doi:10.1038/s41418-018-0173-9
   PubMed Web of Science ®Google Scholar
• Wang Y, Quan F, Cao Q, et al. Quercetin alleviates acute kidney injury by inhibiting ferroptosis. J Adv Res. 2021;28:231–243. doi:10.1016/j.jare.2020.07.007
   PubMed Web of Science ®Google Scholar
• Wen Q, Liu J, Kang R, Zhou B, Tang D. The release and activity of HMGB1 in ferroptosis. Biochem Biophys Res Commun. 2019;510(2):278–283. doi:10.1016/j.bbrc.2019.01.090
   PubMed Web of Science ®Google Scholar
• Luo X, Gong HB, Gao HY, et al. Oxygenated phosphatidylethanolamine navigates phagocytosis of ferroptotic cells by interacting with TLR2. Cell Death Differ. 2021;28(6):1971–1989. doi:10.1038/s41418-020-00719-2
   PubMed Web of Science ®Google Scholar
• Linkermann A, Skouta R, Himmerkus N, et al. Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci U S A. 2014;111(47):16836–16841. doi:10.1073/pnas.1415518111
   PubMed Web of Science ®Google Scholar
• Li W, Feng G, Gauthier JM, et al. Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil recruitment after heart transplantation. J Clin Invest. 2019;129(6):2293–2304. doi:10.1172/jci126428
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang W, Yang H, Shao D, Zhao X, Zhang G. Intraperitoneal injection of 4-hydroxynonenal (4-HNE), a lipid peroxidation product, exacerbates colonic inflammation through activation of Toll-like receptor 4 signaling. Free Radic Biol Med. 2019;131:237–242. doi:10.1016/j.freeradbiomed.2018.11.037
   PubMed Web of Science ®Google Scholar
• Yu Y, Yan Y, Niu F, et al. Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discov. 2021;7(1):193. doi:10.1038/s41420-021-00579-w
   PubMed Web of Science ®Google Scholar
• Chen CJ, Huang HS, Chang WC. Depletion of phospholipid hydroperoxide glutathione peroxidase up-regulates arachidonate metabolism by 12S-lipoxygenase and cyclooxygenase 1 in human epidermoid carcinoma A431 cells. FASEB J. 2003;17(12):1694–1696. doi:10.1096/fj.02-0847fje
   PubMedGoogle Scholar
• Sakamoto H, Imai H, Nakagawa Y. Involvement of phospholipid hydroperoxide glutathione peroxidase in the modulation of prostaglandin D2 synthesis. J Biol Chem. 2000;275(51):40028–40035. doi:10.1074/jbc.M003191200
   PubMed Web of Science ®Google Scholar
• Li C, Deng X, Xie X, Liu Y, Friedmann Angeli JP, Lai L. Activation of glutathione peroxidase 4 as a novel anti-inflammatory strategy. Front Pharmacol. 2018;9:1120. doi:10.3389/fphar.2018.01120
   PubMed Web of Science ®Google Scholar
• Calder PC. Polyunsaturated fatty acids, inflammation, and immunity. Lipids. 2001;36(9):1007–1024. doi:10.1007/s11745-001-0812-7
   PubMed Web of Science ®Google Scholar
• Xie LH, Gwathmey JK, Zhao Z. Cardiac adaptation and cardioprotection against arrhythmias and ischemia-reperfusion injury in mammalian hibernators. Pflugers Arch. 2021;473(3):407–416. doi:10.1007/s00424-020-02511-0
   PubMed Web of Science ®Google Scholar
• Gordan R, Wongjaikam S, Gwathmey JK, Chattipakorn N, Chattipakorn SC, Xie LH. Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update. Heart Fail Rev. 2018;23(5):801–816. doi:10.1007/s10741-018-9700-5
   PubMed Web of Science ®Google Scholar
• Jacobs W, Lammens M, Kerckhofs A, et al. Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID-19): autopsy reveals a ferroptosis signature. ESC Heart Fail. 2020;7(6):3772–3781. doi:10.1002/ehf2.12958
   PubMed Web of Science ®Google Scholar
• Nomani H, Bayat G, Sahebkar A, et al. Atrial fibrillation in β-thalassemia patients with a focus on the role of iron-overload and oxidative stress: a review. J Cell Physiol. 2019;234(8):12249–12266. doi:10.1002/jcp.27968
   PubMed Web of Science ®Google Scholar
• Liu D, Yang M, Yao Y, et al. Cardiac fibroblasts promote ferroptosis in atrial fibrillation by secreting exo-miR-23a-3p targeting SLC7A11. Oxid Med Cell Longev. 2022;2022:3961495. doi:10.1155/2022/3961495
   PubMed Web of Science ®Google Scholar
• Fang J, Kong B, Shuai W, et al. Ferroportin-mediated ferroptosis involved in new-onset atrial fibrillation with LPS-induced endotoxemia. Eur J Pharmacol. 2021;913:174622. doi:10.1016/j.ejphar.2021.174622
   PubMed Web of Science ®Google Scholar
• Dai C, Kong B, Qin T, et al. Inhibition of ferroptosis reduces susceptibility to frequent excessive alcohol consumption-induced atrial fibrillation. Toxicology. 2022;465:153055. doi:10.1016/j.tox.2021.153055
   PubMed Web of Science ®Google Scholar
• Kong B, Fu H, Xiao Z, Zhou Y, Shuai W, Huang H. Gut microbiota dysbiosis induced by a high-fat diet increases susceptibility to atrial fibrillation. Can J Cardiol. 2022. doi:10.1016/j.cjca.2022.08.231
   Web of Science ®Google Scholar
• Yao C, Veleva T, Scott L, et al. Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation. Circulation. 2018;138(20):2227–2242. doi:10.1161/circulationaha.118.035202
   PubMed Web of Science ®Google Scholar
• Wu X, Liu Y, Tu D, et al. Role of NLRP3-inflammasome/caspase-1/galectin-3 pathway on atrial remodeling in diabetic rabbits. J Cardiovasc Transl Res. 2020;13(5):731–740. doi:10.1007/s12265-020-09965-8
   PubMed Web of Science ®Google Scholar
• Chen G, Chelu MG, Dobrev D, Li N. Cardiomyocyte inflammasome signaling in cardiomyopathies and atrial fibrillation: mechanisms and potential therapeutic implications. Front Physiol. 2018;9:1115. doi:10.3389/fphys.2018.01115
   PubMed Web of Science ®Google Scholar
• Luo Y, Zhang Y, Han X, et al. Akkermansia muciniphila prevents cold-related atrial fibrillation in rats by modulation of TMAO induced cardiac pyroptosis. EBioMedicine. 2022;82:104087. doi:10.1016/j.ebiom.2022.104087
   PubMed Web of Science ®Google Scholar
• Yan B, Liu T, Yao C, Liu X, Du Q, Pan L. LncRNA XIST shuttled by adipose tissue-derived mesenchymal stem cell-derived extracellular vesicles suppresses myocardial pyroptosis in atrial fibrillation by disrupting miR-214-3p-mediated Arl2 inhibition. Lab Invest. 2021;101(11):1427–1438. doi:10.1038/s41374-021-00635-0
   PubMed Web of Science ®Google Scholar
• Lavee J, Onik G, Mikus P, Rubinsky B. A novel nonthermal energy source for surgical epicardial atrial ablation: irreversible electroporation. Heart Surg Forum. 2007;10(2):E162–E167. doi:10.1532/hsf98.20061202
   PubMed Web of Science ®Google Scholar
• Ramirez FD, Reddy VY, Viswanathan R, Hocini M, Jaïs P. Emerging Technologies for Pulmonary Vein Isolation. Circ Res. 2020;127(1):170–183. doi:10.1161/circresaha.120.316402
   PubMed Web of Science ®Google Scholar
• Verma A, Haines DE, Boersma LV, et al. Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial. Circulation. 2023. doi:10.1161/CIRCULATIONAHA.123.063988
   Web of Science ®Google Scholar
• Reddy VY, Dukkipati SR, Neuzil P, et al. Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol. 2021;7(5):614–627. doi:10.1016/j.jacep.2021.02.014
   PubMedGoogle Scholar
• Duytschaever MA-O, De Potter TA-OX, Grimaldi MA-O, et al. Paroxysmal atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter integrated with a 3-dimensional mapping system: 1-year outcomes of the multicenter inspIRE study. Circulation. 2023;16(3):e011780.
   PubMed Web of Science ®Google Scholar
• Turagam MA-O, Neuzil PA-O, Schmidt BA-O, et al. Safety and effectiveness of pulsed field ablation to treat atrial fibrillation: one-year outcomes from the MANIFEST-PF Registry. Circulation. 2023;2023:1.
   Google Scholar
• Badertscher P, Weidlich S, Serban T, et al. Pulsed-field ablation versus single-catheter high-power short-duration radiofrequency ablation for atrial fibrillation: procedural characteristics, myocardial injury, and mid-term outcomes. Heart Rhythm. 2023. doi:10.1016/j.hrthm.2023.05.007
   Google Scholar
• Urbanek LA-OX, Bordignon SA-O, Schaack DA-O, et al. Pulsed field versus cryoballoon pulmonary vein isolation for atrial fibrillation: efficacy, safety, and long-term follow-up in a 400-patient cohort. Circulation. 2023;16(7):389–398.
   PubMed Web of Science ®Google Scholar
• Schmidt B, Bordignon S, Tohoku S, et al. 5S study: safe and simple single shot pulmonary vein isolation with pulsed field ablation using sedation. Circ Arrhythm Electrophysiol. 2022;15(6):e010817. doi:10.1161/circep.121.010817
   PubMed Web of Science ®Google Scholar
• Lemoine MD, Fink T, Mencke C, et al. Pulsed-field ablation-based pulmonary vein isolation: acute safety, efficacy and short-term follow-up in a multi-center real world scenario. Clin Res Cardiol. 2022. doi:10.1007/s00392-022-02091-2
   Web of Science ®Google Scholar
• Davong B, Adeliño R, Delasnerie H, et al. Pulsed-field ablation on mitral isthmus in persistent atrial fibrillation: preliminary data on efficacy and safety. JACC. 2023. doi:10.1016/j.jacep.2023.03.021
   Google Scholar
• Wei Y, Chen L, Cao J, et al. Long-term outcomes of a time to isolation - based strategy for cryoballoon ablation compared to radiofrequency ablation in patients with symptomatic paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2022;45(9):1015–1023. doi:10.1111/pace.14556
   PubMed Web of Science ®Google Scholar
• Kühne M, Suter Y, Altmann D, et al. Cryoballoon versus radiofrequency catheter ablation of paroxysmal atrial fibrillation: biomarkers of myocardial injury, recurrence rates, and pulmonary vein reconnection patterns. Heart Rhythm. 2010;7(12):1770–1776. doi:10.1016/j.hrthm.2010.08.028
   PubMed Web of Science ®Google Scholar
• Wasserlauf J, Pelchovitz DJ, Rhyner J, et al. Cryoballoon versus radiofrequency catheter ablation for paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2015;38(4):483–489. doi:10.1111/pace.12582
   PubMed Web of Science ®Google Scholar
• Mugnai G, Chierchia GB, de Asmundis C, et al. Comparison of pulmonary vein isolation using cryoballoon versus conventional radiofrequency for paroxysmal atrial fibrillation. Am J Cardiol. 2014;113(9):1509–1513. doi:10.1016/j.amjcard.2014.01.425
   PubMed Web of Science ®Google Scholar
• Morillo CA, Verma A, Connolly SJ, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA. 2014;311(7):692–700. doi:10.1001/jama.2014.467
   PubMed Web of Science ®Google Scholar
• Cosedis Nielsen J, Johannessen A, Raatikainen P, et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med. 2012;367(17):1587–1595. doi:10.1056/NEJMoa1113566
   PubMed Web of Science ®Google Scholar
• Luik A, Radzewitz A, Kieser M, et al. Cryoballoon versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation: the prospective, randomized, controlled, noninferiority FreezeAF study. Circulation. 2015;132(14):1311–1319. doi:10.1161/circulationaha.115.016871
   PubMed Web of Science ®Google Scholar
• Ouyang F, Tilz R, Chun J, et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation. 2010;122(23):2368–2377. doi:10.1161/circulationaha.110.946806
   PubMed Web of Science ®Google Scholar
• Choi JH, Park SJ, Park KM, Kim JS, On YK. Efficacy and safety of cryoballoon pulmonary vein isolation for paroxysmal and persistent atrial fibrillation: a comparison with radiofrequency ablation. PLoS One. 2022;17(7):e0265482. doi:10.1371/journal.pone.0265482
   PubMed Web of Science ®Google Scholar
• Tanaka N, Tanaka K, Ninomiya Y, et al. Comparison of the safety and efficacy of automated annotation-guided radiofrequency ablation and 2nd-generation cryoballoon ablation in paroxysmal atrial fibrillation. Circ J. 2019;83(3):548–555. doi:10.1253/circj.CJ-18-1035
   PubMed Web of Science ®Google Scholar
• Buist TJ, Adiyaman A, Smit JJJ, Ramdat Misier AR, Elvan A. Arrhythmia-free survival and pulmonary vein reconnection patterns after second-generation cryoballoon and contact-force radiofrequency pulmonary vein isolation. Clin Res Cardiol. 2018;107(6):498–506. doi:10.1007/s00392-018-1211-9
   PubMed Web of Science ®Google Scholar
• Castellá M, Kotecha D, van Laar C, et al. Thoracoscopic vs catheter ablation for atrial fibrillation: long-term follow-up of the FAST randomized trial. Europace. 2019;21(5):746–753. doi:10.1093/europace/euy325
   PubMed Web of Science ®Google Scholar
• Shin DG, Ahn J, Han SJ, Lim HE. Efficacy of high-power and short-duration ablation in patients with atrial fibrillation: a prospective randomized controlled trial. Europace. 2020;22(10):1495–1501. doi:10.1093/europace/euaa144
   PubMed Web of Science ®Google Scholar
• Wójcik M, Erkapic D, Berkowitsch A, et al. Ipsilateral circumferential radiofrequency ablation of atrial fibrillation with irrigated tip catheter: long-term outcome and pre-procedural predictors. Circ J. 2013;77(9):2280–2287. doi:10.1253/circj.cj-13-0275
   PubMed Web of Science ®Google Scholar
• Weerasooriya R, Khairy P, Litalien J, et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol. 2011;57(2):160–166. doi:10.1016/j.jacc.2010.05.061
   PubMed Web of Science ®Google Scholar
• Bertaglia E, Tondo C, De Simone A, et al. Does catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refractory atrial fibrillation ablation: a 6-year multicentre experience. Europace. 2010;12(2):181–187. doi:10.1093/europace/eup349
   PubMed Web of Science ®Google Scholar
• Ciconte G, Baltogiannis G, de Asmundis C, et al. Circumferential pulmonary vein isolation as index procedure for persistent atrial fibrillation: a comparison between radiofrequency catheter ablation and second-generation cryoballoon ablation. Europace. 2015;17(4):559–565. doi:10.1093/europace/euu350
   PubMed Web of Science ®Google Scholar
• Kuck KH, Merkely B, Zahn R, et al. Catheter ablation versus best medical therapy in patients with persistent atrial fibrillation and congestive heart failure: the randomized AMICA trial. Circ Arrhythm Electrophysiol. 2019;12(12):e007731. doi:10.1161/circep.119.007731
   PubMed Web of Science ®Google Scholar
• Pavlović N, Sticherling C, Knecht S, et al. One-year follow-up after irrigated multi-electrode radiofrequency ablation of persistent atrial fibrillation. Europace. 2016;18(1):85–91. doi:10.1093/europace/euv020
   PubMed Web of Science ®Google Scholar
• Shi LB, Rossvoll O, Tande P, Schuster P, Solheim E, Chen J. Cryoballoon vs radiofrequency catheter ablation: insights from Norwegian randomized study of PERSistent Atrial Fibrillation (NO-PERSAF study). Europace. 2022;24(2):226–233. doi:10.1093/europace/euab281
   PubMed Web of Science ®Google Scholar
• Verma A, Jiang C-Y, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372(19):1812–1822. doi:10.1056/NEJMoa1408288
   PubMed Web of Science ®Google Scholar
• Fink T, Schlüter M, Heeger CH, et al. Stand-alone pulmonary vein isolation versus pulmonary vein isolation with additional substrate modification as index ablation procedures in patients with persistent and long-standing persistent atrial fibrillation: the randomized Alster-Lost-AF Trial (Ablation at St. Georg Hospital for Long-Standing Persistent Atrial Fibrillation). Circ Arrhythm Electrophysiol. 2017;10(7). doi:10.1161/circep.117.005114
   Web of Science ®Google Scholar
• Tilz RR, Rillig A, Thum A-M, et al. Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy. J Am Coll Cardiol. 2012;60(19):1921–1929. doi:10.1016/j.jacc.2012.04.060
   PubMed Web of Science ®Google Scholar
• McCready JW, Smedley T, Lambiase PD, et al. Predictors of recurrence following radiofrequency ablation for persistent atrial fibrillation. Europace. 2011;13(3):355–361. doi:10.1093/europace/euq434
   PubMed Web of Science ®Google Scholar
• Wazni OM, Dandamudi G, Sood N, et al. Cryoballoon ablation as initial therapy for atrial fibrillation. N Engl J Med. 2021;384(4):316–324. doi:10.1056/NEJMoa2029554
   PubMed Web of Science ®Google Scholar
• Andrade JG, Wells GA, Deyell MW, et al. Cryoablation or drug therapy for initial treatment of atrial fibrillation. N Engl J Med. 2021;384(4):305–315. doi:10.1056/NEJMoa2029980
   PubMed Web of Science ®Google Scholar
• Andrade JG, Champagne J, Dubuc M, et al. Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: a randomized clinical trial. Circulation. 2019;140(22):1779–1788. doi:10.1161/circulationaha.119.042622
   PubMed Web of Science ®Google Scholar
• Packer DL, Kowal RC, Wheelan KR, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61(16):1713–1723. doi:10.1016/j.jacc.2012.11.064
   PubMed Web of Science ®Google Scholar
• Kuniss M, Pavlovic N, Velagic V, et al. Cryoballoon ablation vs antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation. Europace. 2021;23(7):1033–1041. doi:10.1093/europace/euab029
   PubMed Web of Science ®Google Scholar
• Neumann T, Wójcik M, Berkowitsch A, et al. Cryoballoon ablation of paroxysmal atrial fibrillation: 5-year outcome after single procedure and predictors of success. Europace. 2013;15(8):1143–1149. doi:10.1093/europace/eut021
   PubMed Web of Science ®Google Scholar
• Schiavone M, Gasperetti A, Montemerlo E, et al. Long-term comparisons of atrial fibrillation ablation outcomes with a cryoballoon or laser-balloon: a propensity-matched analysis based on continuous rhythm monitoring. Hell J Cardiol. 2022;65:1–7. doi:10.1016/j.hjc.2022.03.006
   PubMed Web of Science ®Google Scholar
• Wu S-J, Li C-H, Weng C-J, et al. Efficacy of cryoballoon ablation for atrial fibrillation and recurrence predictors in an Asian cohort. J Pers Med. 2022;12(5):732. doi:10.3390/jpm12050732
   PubMed Web of Science ®Google Scholar
• Ferrero-De-Loma-Osorio Á, Cózar R, García-Alberola A, et al. Primary results of the Spanish Cryoballoon Ablation Registry: acute and long-term outcomes of the RECABA study. Sci Rep. 2021;11(1):17268. doi:10.1038/s41598-021-96655-3
   PubMed Web of Science ®Google Scholar
• Chun JKR, Bordignon S, Last J, et al. Cryoballoon versus laserballoon: insights from the first prospective randomized balloon trial in catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2021;14(2):e009294. doi:10.1161/circep.120.009294
   PubMed Web of Science ®Google Scholar
• Knecht S, Sticherling C, Roten L, et al. Efficacy and safety of a novel cryoballoon ablation system: multicentre comparison of 1-year outcome. Europace. 2022. doi:10.1093/europace/euac094
   Web of Science ®Google Scholar
• Chen X, Xia Y, Lin Y, et al. Cryoballoon ablation for treatment of atrial fibrillation in a Chinese population: five-year outcomes and predictors of recurrence after a single procedure. Front Cardiovasc Med. 2022;9:836392. doi:10.3389/fcvm.2022.836392
   PubMed Web of Science ®Google Scholar
• Lim HE, Oh IY, Kueffer FJ, van Bragt KA, On YK. Cryoballoon catheter ablation in Korean patients with paroxysmal and persistent atrial fibrillation: one year outcome from the Cryo Global Registry. Korean Circ J. 2022;52(10):755–767. doi:10.4070/kcj.2022.0127
   PubMed Web of Science ®Google Scholar
• Aytemir K, Oto A, Canpolat U, et al. Immediate and medium-term outcomes of cryoballoon-based pulmonary vein isolation in patients with paroxysmal and persistent atrial fibrillation: single-centre experience. J Interv Card Electrophysiol. 2013;38(3):187–195. doi:10.1007/s10840-013-9834-2
   PubMed Web of Science ®Google Scholar
• Yalin K, Abdin A, Lyan E, et al. Safety and efficacy of persistent atrial fibrillation ablation using the second-generation cryoballoon. Clin Res Cardiol. 2018;107(7):570–577. doi:10.1007/s00392-018-1219-1
   PubMed Web of Science ®Google Scholar
• Lemes C, Wissner E, Lin T, et al. One-year clinical outcome after pulmonary vein isolation in persistent atrial fibrillation using the second-generation 28 mm cryoballoon: a retrospective analysis. Europace. 2016;18(2):201–205. doi:10.1093/europace/euv092
   PubMed Web of Science ®Google Scholar
• Koektuerk B, Yorgun H, Hengeoez O, et al. Cryoballoon ablation for pulmonary vein isolation in patients with persistent atrial fibrillation: one-year outcome using second generation cryoballoon. Circ Arrhythm Electrophysiol. 2015;8(5):1073–1079. doi:10.1161/circep.115.002776
   PubMed Web of Science ®Google Scholar
• Guhl EN, Siddoway D, Adelstein E, Voigt A, Saba S, Jain SK. Efficacy of cryoballoon pulmonary vein isolation in patients with persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27(4):423–427. doi:10.1111/jce.12924
   PubMed Web of Science ®Google Scholar
• Omran H, Gutleben KJ, Molatta S, et al. Second generation cryoballoon ablation for persistent atrial fibrillation: an updated meta-analysis. Clin Res Cardiol. 2018;107(2):182–192. doi:10.1007/s00392-017-1171-5
   PubMed Web of Science ®Google Scholar
• Nikfarjam M, Muralidharan V, Christophi C. Mechanisms of focal heat destruction of liver tumors. J Surg Res. 2005;127(2):208–223. doi:10.1016/j.jss.2005.02.009
   PubMed Web of Science ®Google Scholar
• Yang M, Yang X, Wang S, et al. HMGB1-induced endothelial cell pyroptosis is involved in systemic inflammatory response syndrome following radiofrequency ablation of hepatic hemangiomas. Am J Transl Res. 2019;11(12):7555–7567.
   PubMed Web of Science ®Google Scholar
• Wang S, Yang M, Yang X, et al. Endothelial pyroptosis underlies systemic inflammatory response following radiofrequency ablation of hepatic hemangiomas. Scand J Clin Lab Invest. 2019;79(8):619–628. doi:10.1080/00365513.2019.1689428
   PubMed Web of Science ®Google Scholar
• Wang K, Jiang L, Zhong Y, et al. Ferrostatin-1-loaded liposome for treatment of corneal alkali burn via targeting ferroptosis. Bioeng Transl Med. 2022;7(2):e10276. doi:10.1002/btm2.10276
   PubMed Web of Science ®Google Scholar
• Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208. doi:10.1038/nrc3672
   PubMed Web of Science ®Google Scholar
• Gao D, Critser JK. Mechanisms of cryoinjury in living cells. ILAR J. 2000;41(4):187–196. doi:10.1093/ilar.41.4.187
   PubMedGoogle Scholar
• Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology. 2002;60(2 Suppl 1):40–49. doi:10.1016/s0090-4295(02)01683-7
   PubMed Web of Science ®Google Scholar
• Hanai A, Yang WL, Ravikumar TS. Induction of apoptosis in human colon carcinoma cells HT29 by sublethal cryo-injury: mediation by cytochrome c release. Int J Cancer. 2001;93(4):526–533. doi:10.1002/ijc.1359
   PubMed Web of Science ®Google Scholar
• Yang WL, Addona T, Nair DG, Qi L, Ravikumar TS. Apoptosis induced by cryo-injury in human colorectal cancer cells is associated with mitochondrial dysfunction. Int J Cancer. 2003;103(3):360–369. doi:10.1002/ijc.10822
   PubMed Web of Science ®Google Scholar
• Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33(2):223–231. doi:10.1007/s10439-005-8981-8
   PubMed Web of Science ®Google Scholar
• Yarmush ML, Golberg A, Serša G, Kotnik T, Miklavčič D. Electroporation-based technologies for medicine: principles, applications, and challenges. Annu Rev Biomed Eng. 2014;16:295–320. doi:10.1146/annurev-bioeng-071813-104622
   PubMed Web of Science ®Google Scholar
• Freeman SA, Wang MA, Weaver JC. Theory of electroporation of planar bilayer membranes: predictions of the aqueous area, change in capacitance, and pore-pore separation. Biophys J. 1994;67(1):42–56. doi:10.1016/s0006-3495(94)80453-9
   PubMed Web of Science ®Google Scholar
• Chen W, Zhongsheng Z, Lee RC. Supramembrane potential-induced electroconformational changes in sodium channel proteins: a potential mechanism involved in electric injury. Burns. 2006;32(1):52–59. doi:10.1016/j.burns.2005.08.008
   PubMed Web of Science ®Google Scholar
• Frandsen SK, Gissel H, Hojman P, Tramm T, Eriksen J, Gehl J. Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. Cancer Res. 2012;72(6):1336–1341. doi:10.1158/0008-5472.Can-11-3782
   PubMed Web of Science ®Google Scholar
• Batista Napotnik T, Polajžer T, Miklavčič D. Cell death due to electroporation - A review. Bioelectrochemistry. 2021;141:107871. doi:10.1016/j.bioelechem.2021.107871
   PubMed Web of Science ®Google Scholar
• Lee EW, Loh CT, Kee ST. Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation. Technol Cancer Res Treat. 2007;6(4):287–294. doi:10.1177/153303460700600404
   PubMed Web of Science ®Google Scholar
• Kim HB, Sung CK, Baik KY, et al. Changes of apoptosis in tumor tissues with time after irreversible electroporation. Biochem Biophys Res Commun. 2013;435(4):651–656. doi:10.1016/j.bbrc.2013.05.039
   PubMed Web of Science ®Google Scholar
• Long G, Bakos G, Shires PK, et al. Histological and finite element analysis of cell death due to irreversible electroporation. Technol Cancer Res Treat. 2014;13(6):561–569. doi:10.7785/tcrtexpress.2013.600253
   PubMed Web of Science ®Google Scholar
• van den Bos W, Jurhill RR, de Bruin DM, et al. Histopathological outcomes after irreversible electroporation for prostate cancer: results of an ablate and resect study. J Urol. 2016;196(2):552–559. doi:10.1016/j.juro.2016.02.2977
   PubMed Web of Science ®Google Scholar
• Jose A, Sobrevals L, Ivorra A, Fillat C. Irreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse models. Cancer Lett. 2012;317(1):16–23. doi:10.1016/j.canlet.2011.11.004
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lyu C, Liu Y, Lv Y, Chang TT, Rubinsky B. Molecular and histological study on the effects of non-thermal irreversible electroporation on the liver. Biochem Biophys Res Commun. 2018;500(3):665–670. doi:10.1016/j.bbrc.2018.04.132
   PubMed Web of Science ®Google Scholar
• Klein Klouwenberg PM, Frencken JF, Kuipers S, et al. Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis. A cohort study. Am J Respir Crit Care Med. 2017;195(2):205–211. doi:10.1164/rccm.201603-0618OC
   PubMed Web of Science ®Google Scholar
• Meierhenrich R, Steinhilber E, Eggermann C, et al. Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study. Crit Care. 2010;14(3):R108. doi:10.1186/cc9057
   PubMed Web of Science ®Google Scholar
• Bacani AK, Crowson CS, Roger VL, Gabriel SE, Matteson EL. Increased incidence of atrial fibrillation in patients with rheumatoid arthritis. Biomed Res Int. 2015;2015:809514. doi:10.1155/2015/809514
   PubMed Web of Science ®Google Scholar
• Ahlehoff O, Gislason GH, Jørgensen CH, et al. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. Eur Heart J. 2012;33(16):2054–2064. doi:10.1093/eurheartj/ehr285
   PubMed Web of Science ®Google Scholar
• Choi YJ, Choi EK, Han KD, et al. Increased risk of atrial fibrillation in patients with inflammatory bowel disease: a nationwide population-based study. World J Gastroenterol. 2019;25(22):2788–2798. doi:10.3748/wjg.v25.i22.2788
   PubMed Web of Science ®Google Scholar
• Zhao Q, Zhang S, Zhao H, et al. Median nerve stimulation prevents atrial electrical remodelling and inflammation in a canine model with rapid atrial pacing. Europace. 2018;20(4):712–718. doi:10.1093/europace/eux003
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sun D, Zhao X, et al. Bacteroides fragilis prevents aging-related atrial fibrillation in rats via regulatory T cells-mediated regulation of inflammation. Pharmacol Res. 2022;177:106141. doi:10.1016/j.phrs.2022.106141
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhang F, Yang M, Zhong J. Increasing level of Interleukin-1β in epicardial adipose tissue is associated with persistent atrial fibrillation. J Interferon Cytokine Res. 2020;40(1):64–69. doi:10.1089/jir.2019.0098
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Nakamura K, Fukushima-Kusano K, et al. Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis. Thromb Res. 2003;111(3):137–142. doi:10.1016/s0049-3848(03)00405-5
   PubMed Web of Science ®Google Scholar
• Narducci ML, Pelargonio G, Dello Russo A, et al. Role of tissue C-reactive protein in atrial cardiomyocytes of patients undergoing catheter ablation of atrial fibrillation: pathogenetic implications. Europace. 2011;13(8):1133–1140. doi:10.1093/europace/eur068
   PubMed Web of Science ®Google Scholar
• Soeki T, Bando S, Uematsu E, et al. Pentraxin 3 is a local inflammatory marker in atrial fibrillation. Heart Vessels. 2014;29(5):653–658. doi:10.1007/s00380-013-0400-8
   PubMed Web of Science ®Google Scholar
• Musa H, Kaur K, O’Connell R, et al. Inhibition of platelet-derived growth factor-AB signaling prevents electromechanical remodeling of adult atrial myocytes that contact myofibroblasts. Heart Rhythm. 2013;10(7):1044–1051. doi:10.1016/j.hrthm.2013.03.014
   PubMed Web of Science ®Google Scholar
• Lee SH, Chen YC, Chen YJ, et al. Tumor necrosis factor-alpha alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes. Life Sci. 2007;80(19):1806–1815. doi:10.1016/j.lfs.2007.02.029
   PubMed Web of Science ®Google Scholar
• Saba S, Janczewski AM, Baker LC, et al. Atrial contractile dysfunction, fibrosis, and arrhythmias in a mouse model of cardiomyopathy secondary to cardiac-specific overexpression of tumor necrosis factor-{alpha}. Am J Physiol Heart Circ Physiol. 2005;289(4):H1456–H1467. doi:10.1152/ajpheart.00733.2004
   PubMed Web of Science ®Google Scholar
• Sawaya SE, Rajawat YS, Rami TG, et al. Downregulation of connexin40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac-restricted overexpression of tumor necrosis factor. Am J Physiol Heart Circ Physiol. 2007;292(3):H1561–H1567. doi:10.1152/ajpheart.00285.2006
   PubMed Web of Science ®Google Scholar
• Ryu K, Li L, Khrestian CM, et al. Effects of sterile pericarditis on connexins 40 and 43 in the atria: correlation with abnormal conduction and atrial arrhythmias. Am J Physiol Heart Circ Physiol. 2007;293(2):H1231–H1241. doi:10.1152/ajpheart.00607.2006
   PubMed Web of Science ®Google Scholar
• Lazzerini PE, Laghi-Pasini F, Acampa M, et al. Systemic inflammation rapidly induces reversible atrial electrical remodeling: the role of interleukin-6-mediated changes in connexin expression. J Am Heart Assoc. 2019;8(16):e011006. doi:10.1161/jaha.118.011006
   PubMed Web of Science ®Google Scholar
• Ishii Y, Schuessler RB, Gaynor SL, et al. Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation. 2005;111(22):2881–2888. doi:10.1161/circulationaha.104.475194
   PubMed Web of Science ®Google Scholar
• Tselentakis EV, Woodford E, Chandy J, Gaudette GR, Saltman AE. Inflammation effects on the electrical properties of atrial tissue and inducibility of postoperative atrial fibrillation. J Surg Res. 2006;135(1):68–75. doi:10.1016/j.jss.2006.03.024
   PubMed Web of Science ®Google Scholar
• Wilhelm M, Zueger T, De Marchi S, et al. Inflammation and atrial remodeling after a mountain marathon. Scand J Med Sci Sports. 2014;24(3):519–525. doi:10.1111/sms.12030
   PubMed Web of Science ®Google Scholar
• Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol. 2008;51(8):802–809. doi:10.1016/j.jacc.2007.09.064
   PubMed Web of Science ®Google Scholar
• Liao CH, Akazawa H, Tamagawa M, et al. Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts. J Clin Invest. 2010;120(1):242–253. doi:10.1172/jci39942
   PubMed Web of Science ®Google Scholar
• Hoogstra-Berends F, Meijering RA, Zhang D, et al. Heat shock protein-inducing compounds as therapeutics to restore proteostasis in atrial fibrillation. Trends Cardiovasc Med. 2012;22(3):62–68. doi:10.1016/j.tcm.2012.06.013
   PubMed Web of Science ®Google Scholar
• Liew R, Khairunnisa K, Gu Y, et al. Role of tumor necrosis factor-α in the pathogenesis of atrial fibrosis and development of an arrhythmogenic substrate. Circ J. 2013;77(5):1171–1179. doi:10.1253/circj.cj-12-1155
   PubMed Web of Science ®Google Scholar
• Li YY, Feng YQ, Kadokami T, et al. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. Proc Natl Acad Sci U S A. 2000;97(23):12746–12751. doi:10.1073/pnas.97.23.12746
   PubMed Web of Science ®Google Scholar
• Ma F, Li Y, Jia L, et al. Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF β/Smad activation and cardiac fibrosis induced by angiotensin II. PLoS One. 2012;7(5):e35144. doi:10.1371/journal.pone.0035144
   PubMed Web of Science ®Google Scholar
• Hu YF, Yeh HI, Tsao HM, et al. Electrophysiological correlation and prognostic impact of heat shock protein 27 in atrial fibrillation. Circ Arrhythm Electrophysiol. 2012;5(2):334–340. doi:10.1161/circep.111.965996
   PubMed Web of Science ®Google Scholar
• Psychari SN, Apostolou TS, Sinos L, Hamodraka E, Liakos G, Kremastinos DT. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol. 2005;95(6):764–767. doi:10.1016/j.amjcard.2004.11.032
   PubMed Web of Science ®Google Scholar
• Luan Y, Guo Y, Li S, et al. Interleukin-18 among atrial fibrillation patients in the absence of structural heart disease. Europace. 2010;12(12):1713–1718. doi:10.1093/europace/euq321
   PubMed Web of Science ®Google Scholar
• Sabel MS. Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology. 2009;58(1):1–11. doi:10.1016/j.cryobiol.2008.10.126
   PubMed Web of Science ®Google Scholar
• Ahmad F, Gravante G, Bhardwaj N, et al. Changes in interleukin-1β and 6 after hepatic microwave tissue ablation compared with radiofrequency, cryotherapy and surgical resections. Am J Surg. 2010;200(4):500–506. doi:10.1016/j.amjsurg.2009.12.025
   PubMed Web of Science ®Google Scholar
• Erinjeri JP, Thomas CT, Samoilia A, et al. Image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10. J Vasc Interv Radiol. 2013;24(8):1105–1112. doi:10.1016/j.jvir.2013.02.015
   PubMed Web of Science ®Google Scholar
• Fietta AM, Morosini M, Passadore I, et al. Systemic inflammatory response and downmodulation of peripheral CD25+Foxp3+ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer. Hum Immunol. 2009;70(7):477–486. doi:10.1016/j.humimm.2009.03.012
   PubMed Web of Science ®Google Scholar
• Zerbini A, Pilli M, Laccabue D, et al. Radiofrequency thermal ablation for hepatocellular carcinoma stimulates autologous NK-cell response. Gastroenterology. 2010;138(5):1931–1942. doi:10.1053/j.gastro.2009.12.051
   PubMed Web of Science ®Google Scholar
• Wissniowski TT, Hänsler J, Neureiter D, et al. Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits. Cancer Res. 2003;63(19):6496–6500.
   PubMed Web of Science ®Google Scholar
• Dromi SA, Walsh MP, Herby S, et al. Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity. Radiology. 2009;251(1):58–66. doi:10.1148/radiol.2511072175
   PubMed Web of Science ®Google Scholar
• Oswald H, Gardiwal A, Lissel C, Yu H, Klein G. Difference in humoral biomarkers for myocardial injury and inflammation in radiofrequency ablation versus cryoablation. Pacing Clin Electrophysiol. 2007;30(7):885–890. doi:10.1111/j.1540-8159.2007.00776.x
   PubMed Web of Science ®Google Scholar
• Herrera Siklódy C, Arentz T, Minners J, et al. Cellular damage, platelet activation, and inflammatory response after pulmonary vein isolation: a randomized study comparing radiofrequency ablation with cryoablation. Heart Rhythm. 2012;9(2):189–196. doi:10.1016/j.hrthm.2011.09.017
   PubMed Web of Science ®Google Scholar
• Antolič B, Pernat A, Cvijić M, Žižek D, Jan M, Šinkovec M. Radiofrequency catheter ablation versus balloon cryoablation of atrial fibrillation: markers of myocardial damage, inflammation, and thrombogenesis. Wien Klin Wochenschr. 2016;128(13–14):480–487. doi:10.1007/s00508-016-1002-0
   PubMed Web of Science ®Google Scholar
• Miyazaki S, Kuroi A, Hachiya H, et al. Early recurrence after pulmonary vein isolation of paroxysmal atrial fibrillation with different ablation technologies - prospective comparison of radiofrequency vs second-generation cryoballoon ablation. Circ J. 2016;80(2):346–353. doi:10.1253/circj.CJ-15-1051
   PubMed Web of Science ®Google Scholar
• Grimaldi M, Di monaco A, Gomez T, et al. Time course of irreversible electroporation lesion development through short- and long-term follow-up in pulsed-field ablation-treated hearts. Circ Arrhythm Electrophysiol. 2022;15(7):e010661. doi:10.1161/circep.121.010661
   PubMed Web of Science ®Google Scholar
• Koruth JS, Kuroki K, Kawamura I, et al. Focal pulsed field ablation for pulmonary vein isolation and linear atrial lesions: a preclinical assessment of safety and durability. Circ Arrhythm Electrophysiol. 2020;13(6):e008716. doi:10.1161/circep.120.008716
   PubMed Web of Science ®Google Scholar
• Sugimoto K, Kakimi K, Takeuchi H, et al. Irreversible electroporation versus radiofrequency ablation: comparison of systemic immune responses in patients with hepatocellular carcinoma. JVIR. 2019;30(6):845–853.e846. doi:10.1016/j.jvir.2019.03.002
   Google Scholar
• Xie B, Chen BX, Nanna M, et al. 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging in atrial fibrillation: a pilot prospective study. Eur Heart J Cardiovasc Imaging. 2021;23(1):102–112. doi:10.1093/ehjci/jeab088
   PubMed Web of Science ®Google Scholar
• Chang TY, Hsiao YW, Guo SM, et al. Resistin as a biomarker for the prediction of left atrial substrate and recurrence in patients with drug-refractory atrial fibrillation undergoing catheter ablation. Int Heart J. 2020;61(3):517–523. doi:10.1536/ihj.19-680
   PubMed Web of Science ®Google Scholar
• Kusayama T, Furusho H, Kashiwagi H, et al. Inflammation of left atrial epicardial adipose tissue is associated with paroxysmal atrial fibrillation. J Cardiol. 2016;68(5):406–411. doi:10.1016/j.jjcc.2015.11.005
   PubMed Web of Science ®Google Scholar
• Yorgun H, Canpolat U, Aytemir K, et al. Association of epicardial and peri-atrial adiposity with the presence and severity of non-valvular atrial fibrillation. Int J Cardiovasc Imaging. 2015;31(3):649–657. doi:10.1007/s10554-014-0579-5
   PubMed Web of Science ®Google Scholar
• Hayıroğlu Mİ, Altay SAO. The role of artificial intelligence in coronary artery disease and atrial fibrillation. Balkan Med J. 2023;40(3):151.
   PubMed Web of Science ®Google Scholar
• Andrade JG, Khairy P, Macle L, et al. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation. Circulation. 2014;7(1):69–75. doi:10.1161/circep.113.000586
   PubMed Web of Science ®Google Scholar
• Hernández-Romero D, Marín F, Roldán V, et al. Comparative determination and monitoring of biomarkers of necrosis and myocardial remodeling between radiofrequency ablation and cryoablation. Pacing Clin Electrophysiol. 2013;36(1):31–36. doi:10.1111/pace.12017
   PubMed Web of Science ®Google Scholar
• Del Rey JM, Madrid AH, Novo L, et al. Evaluación de marcadores de lesión miocárdica tras la ablación con radiofrecuencia. Utilidad de la troponina I [Evaluation of biochemical markers of myocardial lesion after radiofrequency ablation. Value of troponin I]. Rev Esp Cardiol. 1997;50(8):552–560. Spanish. doi:10.1016/s0300-8932(97)73263-9
   PubMed Web of Science ®Google Scholar
• Bai Y, Guo SD, Liu Y, Ma CS, Lip GYH. Relationship of troponin to incident atrial fibrillation occurrence, recurrence after radiofrequency ablation and prognosis: a systematic review, meta-analysis and meta-regression. Biomarkers. 2018;23(6):512–517. doi:10.1080/1354750x.2018.1463562
   PubMed Web of Science ®Google Scholar
• Canpolat U, Aytemir K, Yorgun H, et al. Role of preablation neutrophil/lymphocyte ratio on outcomes of cryoballoon-based atrial fibrillation ablation. Am J Cardiol. 2013;112(4):513–519. doi:10.1016/j.amjcard.2013.04.015
   PubMed Web of Science ®Google Scholar
• Guo X, Zhang S, Yan X, et al. Postablation neutrophil/lymphocyte ratio correlates with arrhythmia recurrence after catheter ablation of lone atrial fibrillation. Chin Med J. 2014;127(6):1033–1038.
   PubMed Web of Science ®Google Scholar
• Ruan ZB, Gao RF, Wang F, et al. Circulating galectin-3 and aldosterone for predicting atrial fibrillation recurrence after radiofrequency catheter ablation. Cardiovasc Ther. 2022;2022:6993904. doi:10.1155/2022/6993904
   PubMed Web of Science ®Google Scholar
• Clementy N, Benhenda N, Piver E, et al. Serum galectin-3 levels predict recurrences after ablation of atrial fibrillation. Sci Rep. 2016;6:34357. doi:10.1038/srep34357
   PubMed Web of Science ®Google Scholar
• Berger WR, Jagu B, van den Berg NWE, et al. The change in circulating galectin-3 predicts absence of atrial fibrillation after thoracoscopic surgical ablation. Europace. 2018;20(5):764–771. doi:10.1093/europace/eux090
   PubMed Web of Science ®Google Scholar
• Takemoto Y, Ramirez RJ, Yokokawa M, et al. Galectin-3 regulates atrial fibrillation remodeling and predicts catheter ablation outcomes. Basic Transl Sci. 2016;1(3):143–154. doi:10.1016/j.jacbts.2016.03.003
   PubMedGoogle Scholar
• Karataş MAO, Durmuş G, Zengin A, et al. Association of uric acid albumin ratio with recurrence of atrial fibrillation after cryoballoon catheter ablation. Medicina. 2022;58(12):1872.
   PubMedGoogle Scholar
• Li SB, Yang F, Jing L, et al. Myeloperoxidase and risk of recurrence of atrial fibrillation after catheter ablation. J Investig Med. 2013;61(4):722–727. doi:10.2310/JIM.0b013e3182857fa0
   PubMed Web of Science ®Google Scholar
• Richter B, Gwechenberger M, Socas A, et al. Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation. Clin Res Cardiol. 2012;101(3):217–225. doi:10.1007/s00392-011-0383-3
   PubMed Web of Science ®Google Scholar
• Canpolat U, Aytemir K, Yorgun H, et al. The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation. Europace. 2015;17(12):1807–1815. doi:10.1093/europace/euu291
   PubMed Web of Science ®Google Scholar
• Gurses KM, Kocyigit D, Yalcin MU, et al. Monocyte toll-like receptor expression in patients with atrial fibrillation. Am J Cardiol. 2016;117(9):1463–1467. doi:10.1016/j.amjcard.2016.02.014
   PubMed Web of Science ®Google Scholar
• Kimura T, Takatsuki S, Inagawa K, et al. Serum inflammation markers predicting successful initial catheter ablation for atrial fibrillation. Heart Lung Circ. 2014;23(7):636–643. doi:10.1016/j.hlc.2014.02.003
   PubMed Web of Science ®Google Scholar
• Meyre PB, Sticherling C, Spies F, et al. C-reactive protein for prediction of atrial fibrillation recurrence after catheter ablation. BMC Cardiovasc Disord. 2020;20(1):427. doi:10.1186/s12872-020-01711-x
   PubMed Web of Science ®Google Scholar
• Ihara K, Sasano T. Role of inflammation in the pathogenesis of atrial fibrillation. Front Physiol. 2022;13:862164. doi:10.3389/fphys.2022.862164
   PubMed Web of Science ®Google Scholar
• Farkowski MM, Maciag A, Kowalik I, Konka M, Szwed H, Pytkowski M. Intravenous antazoline, a first-generation antihistaminic drug with antiarrhythmic properties, is a suitable agent for pharmacological cardioversion of atrial fibrillation induced during pulmonary vein isolation due to the lack of influence on atrio-venous conduction and high clinical effectiveness (AntaEP Study). Br J Clin Pharmacol. 2019;85(7):1552–1558. doi:10.1111/bcp.13940
   PubMed Web of Science ®Google Scholar